FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells.
Abstract
The transcription factor FOXP3 has been identified as a tumour suppressor in the breast and prostate epithelia, but little is known about its specific mechanism of action.
We have identified a feed-forward regulatory loop in which FOXP3 suppresses the expression of the oncogene SATB1. In particular, we demonstrate that SATB1 is not only a direct target of FOXP3 repression, but that FOXP3 also induces two miRs, miR-7 and miR-155, which specifically target the 3'-UTR of SATB1 to further regulate its expression.
We conclude that FOXP3-regulated miRs form part of the mechanism by which FOXP3 prevents the transformation of the healthy breast epithelium to a cancerous phenotype.
Approaches aimed at restoring FOXP3 function and the miRs it regulates could help provide new approaches to target breast cancer.
Full Text
Subjects
Similar articles
- MicroRNA-191, an estrogen responsive microRNA, functions as an oncogenic regulator in human breast cancer. (2013-03-29)
- Chromatin organizer SATB1 as a novel molecular target for cancer therapy. (2012-08-08)
- SATB1 collaborates with loss of p16 in cellular transformation. (2013-05-20)
- Pro-oncogenic factors miR-23b- and miR-27b are regulated by Her2/Neu, EGF, and TNFα in breast cancer. (2013-01-21)
- microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. (2013-03-28)
- Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. (2010-01-05)
- WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. (2011-07-27)
- MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. (2010-04-16)
- miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. (2012-12-11)
Authors
Publication date
2012-02-23
Journal
OncogeneOncogene
(1476-5594)Journal topics
Language
Eng.
Copyright
Oncogene
Women's and Children's Health Research Institute, Molecular Immunology Laboratory, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia.
Release reference
Oncogene. 2012 Feb;31(8):1045-54
Related books
